3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Ovarian Neoplasms
55
Small Cell Lung Carcinoma
39
Lung Neoplasms
30
Carcinoma, Ovarian Epithelial
29
Neuroblastoma
25
Fallopian Tube Neoplasms
23
Uterine Cervical Neoplasms
18
Neoplasms
18
Leukemia
18
Leukemia, Myeloid, Acute
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Sarcoma
10
Lymphoma
10
Brain Neoplasms
9
Recurrence
8
Carcinoma, Non-Small-Cell Lung
8
Unspecified Adult Solid Tumor, Protocol Specific
7
Neoplasm Metastasis
7
Myelodysplastic Syndromes
7
Burkitt Lymphoma
7
Blast Crisis
7
Neuroectodermal Tumors, Primitive, Peripheral
6
Lymphoma, Non-Hodgkin
6
Lymphoma, Large B-Cell, Diffuse
6
Lymphoma, Follicular
6
Leukemia, Myelomonocytic, Chronic
6
Leukemia, Myelomonocytic, Acute
6
Leukemia, Monocytic, Acute
6
Leukemia, Megakaryoblastic, Acute
6
Leukemia, Erythroblastic, Acute
6
Interventions
ziprasidone
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Vaccines
1
Tranexamic Acid
1
Topotecan
1
Tobramycin
1
Thrombin
1
TachoSil
1
Spironolactone
1
Sevelamer
1
Rocuronium
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Papillomavirus Vaccines
1
Oxycodone
1
Nifedipine
1
Nafcillin
1
Molindone
1
Methylprednisolone
1
Lurasidone Hydrochloride
1
Labetalol
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Haloperidol
1
Fosfomycin
1
Cytarabine
1
Clozapine
1
Ciprofloxacin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Meningitis
×
Topotecan
×
Clear all
NCT00674674
2012-05-15
PBTC-019
Baylor College of Medicine
Phase 1
Completed
22 enrolled